Annual Report 2021

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2021 144 The United Laboratories International Holdings Limited Annual Report 2021 38. FINANCIAL INSTRUMENTS (Continued) Financial risk management objectives and policies (Continued) Credit risk and impairment assessment (Continued) Changes in the loss allowance for other receivables are mainly due to: 31/12/2021 31/12/2020 Increase (decrease) in 12m ECL Decrease in Lifetime ECL (not credit- impaired) Increase in Lifetime ECL (credit- impaired) (Decrease) increase in 12m ECL Increase in Lifetime ECL (not credit- impaired) RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 One debtor with a gross carrying amount of nil (2020: RMB773,693,000) transferred to lifetime ECL (not-credit impaired) – – – (8,821) 8,821 One debtor with a gross carrying amount of RMB339,574,000 (2020: nil) defaulted and transferred to credit impaired – (44,709) 44,709 – – Additional ECL on one debtor with a gross carrying amount of RMB339,574,000 (2020: RMB552,498,000) – – 294,865 – 71,278 Settlement by one debtor with a gross carrying amount of RMB244,110,000 (2020: RMB300,000,000) – (5,185) – (4,562) – Written off of one debtor with a gross carrying amount of RMB244,110,000 (2020: nil) – (30,205) – – – Newly originated other receivable balance with gross amount of RMB125,431,000 (2020: RMB101,726,000) 9,967 – – 5,700 – Settlement in full of other receivables with a gross carrying amount of RMB101,726,000 (2020: RMB29,739,000) (5,700) – – (3,034) –